This inventor holds 1 USPTO granted patent. Top assignee: Step Pharma S.a.s.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Pascal George
Introduction
Pascal George is a notable inventor recognized for his contributions to the field of pharmaceuticals. He has developed innovative compounds that have the potential to address significant health challenges. His work focuses on creating effective treatments for proliferative diseases.
Latest Patents
Pascal George holds a patent for N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
George is currently associated with Step Pharma S.a.s., where he continues to innovate and develop new therapeutic solutions. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of drug development.
Collaborations
He has collaborated with talented individuals such as Abdul Quddus and Andrew Novak, enhancing the scope and impact of his research. These partnerships have allowed for a more comprehensive approach to tackling complex medical issues.
Conclusion
Pascal George's innovative work and dedication to developing new treatments exemplify the spirit of invention in the pharmaceutical field. His contributions are paving the way for future advancements in medicine.